2024/03/28 08:11:26 | |
---|---|
Price | |
8.09 EUR | |
Difference | 0.87% (0.07) |
ISIN | ES0157097017 |
Symbol | ALM |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,731 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 8.09 EUR |
High | 8.09 EUR |
Low | 8.09 EUR |
Close (prev. day) | 8.02 EUR |
VWAP | 7.79 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 0 |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 08:11:26 | |
---|---|
Price | |
8.09 EUR | |
Difference | 0.87% (0.07) |
ISIN | ES0157097017 |
Symbol | ALM |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,731 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 8.09 EUR |
High | 8.09 EUR |
Low | 8.09 EUR |
Close (prev. day) | 8.02 EUR |
VWAP | 7.79 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -11.92% | -6.58% | -31.96% |
Perf (abs.) | -1.10 | -0.57 | -3.80 |
Beta | 0.65 | 0.46 | 0.49 |
Volatility | 25.42 | 24.98 | 29.52 |
Ø price 5 days | Ø volume 5 days (pcs.) | 7.97 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 8.09 EUR (22) |
Ø price 100 days | Ø volume 100 days (pcs.) | 8.32 EUR (15) |
Ø price 250 days | Ø volume 250 days (pcs.) | 8.55 EUR (24) |
YTD High | date | 8.88 EUR (2024/02/20) |
YTD Low | date | 7.79 EUR (2024/03/20) |
52 Weeks High | date | 9.79 EUR (2023/09/20) |
52 Weeks Low | date | 7.43 EUR (2023/06/28) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/03/27 | 09:05 | 8.215 EUR | 0.00 | 3 |
Tradegate | 2024/03/28 | 22:26 | 8.275 EUR | 0.00 | 1 |
Stuttgart | 2024/03/28 | 16:06 | 8.18 EUR | 0.00 | 10 |
Munich | 2024/03/28 | 08:16 | 8.09 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/03/28 | 17:30 | 8.2325 EUR | 0.00 | 2 |
Frankfurt | 2024/03/28 | 08:11 | 8.09 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/01/26 | 17:57 | 9.51 USD | 0.00 | 1 |
Duesseldorf | 2024/03/28 | 19:31 | 8.21 EUR | 0.00 | 7 |
Berlin | 2024/03/28 | 08:16 | 8.09 EUR | 0.00 | 2 |
BME Continuous Market | 2024/03/28 | 17:35 | 8.265 EUR | 1.62 | 660 |
ALMIRALL SA |
- - |
Ronda General Mitre, 151 - 08022 Barcelona |
Telefon: +34-93-291-30-00 |
Fax: +34-93-291-31-80 |
E-mail: corporate.communication@almirall.com |
Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain. |
Gianfranco Nazzi | Chairman of Managing Board |
Amita Kent | Member of Executive Committee |
Eloi Crespo Cervera | Member of Executive Committee |
Esteve Conesa Panicot | Member of Executive Committee |
Francesca Domenech Wuttke | Member of Executive Committee |
Joan Figueras Carreras | Member of Executive Committee |
Karl Ziegelbauer | Member of Executive Committee |
Mike McClellan | Member of Executive Committee |
Pablo Álvarez | Member of Executive Committee |
Volker Koscielny | Member of Executive Committee |
Alexandra Kimball | Member of Supervisory Board |
Karin Louise Dorrepaal | Member of Supervisory Board |
Ruud Dobber | Member of Supervisory Board |
Seth Orlow | Member of Supervisory Board |
Thomas McKillop | Member of Supervisory Board |
Antonio Gallardo Torrededía | Member of Supervisory Board |
Enrique de Leyva Pérez | Member of Supervisory Board |
Eva-Lotta Allan | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer